Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep724 | Pituitary: clinical | ECE2015

Serum cortisol in the early postoperative period as predictor of remission in Cushing's disease

Oliveira Joana , Lau Eva , Belo Sandra , Freitas Paula , Vinha Eduardo , Pereira Josue , Castro Ligia , Carvalho Davide

Introduction: Pituitary surgery is currently considered the preferred treatment for Cushing’s disease (CD) and achieves remission in 55–85% of patients. Cortisol falls quickly after surgery, so that early post-operative cortisol level has been used as predictor of remission. There’s no agreement about optimal timing for cortisol measurement, with wide variability between centres.Objective: To assess the value of early post-operative serum ...

ea0037ep725 | Pituitary: clinical | ECE2015

Predictive factors for remission and recurrence in Cushing's disease: a single-centre study

Oliveira Joana , Lau Eva , Belo Sandra , Freitas Paula , Vinha Eduardo , Pereira Josue , Castro Ligia , Carvalho Davide

Introduction: Cushing’s disease (CD) is characterised by pathologic hypercortisolism caused by an ACTH-secreting pituitary adenoma. The primary modality for definitive treatment is pituitary surgery. The rarity of CD has made it difficult to establish reliable predictive factors of outcomes.Aim: Assessment of clinical, hormonal, radiological, surgical and histological findings as predictors of remission and relapse of CD.Metho...

ea0037ep865 | Thyroid cancer | ECE2015

Incidental papillary thyroid carcinoma prevalence in benign multinodular goitre: data from Northern Portugal

Pereira Maria Teresa , de Carvalho Andre Couto , Freitas Claudia , Borges Fatima

Introduction: Incidental papillary thyroid carcinoma (PTC) in patients undergoing thyroidectomy for benign multinodular disease is a well-recognised finding. Its true prevalence remains uncertain and shows great variability between studies, ranging from 7–25%. Our purpose was to review the prevalence of PTC in thyroid glands removed for benign nodular disease at a Northern Portuguese tertiary hospital.Methods: From December 2012 to December 2014, th...

ea0035p329 | Clinical case reports Thyroid/Others | ECE2014

Two serious complications of propylthiouracil treatment in the same patient: case report

Garrido Susana , Pereira Teresa , Marinho Antonio , Freitas Claudia , Vilaverde Joana , Amaral Claudia , Carvalho Andre , Borges Fatima

Introduction: Thionamides are important drugs in the treatment of hyperthyroidism. Despite that, they can be associated with rare but serious complications, which require drug discontinuation.Case report: Sixty-five-year-old woman with Graves’ disease, treated in 2002 with methimazole and in remission until 2012. Recurrence of Graves’ disease was diagnosed in March 2012 and she was started on propylthiouracil (PTU) 150 mg per day. She presented...

ea0035p457 | Diabetes complications | ECE2014

Diabetic ketoacidosis and olanzapine: case report

Garrido Susana , Pereira Teresa , Freitas Claudia , Vilaverde Joana , Amaral Claudia , Carvalho Andre , Borges Fatima

Introduction: Patients with psychotic or depressive disorders have an increased risk of developing metabolic syndrome, not only because of their unhealthy lifestyle (sedentary habits, inadequate diet and smoking) but also because of the negative impact of antipsychotic agents (specially clozapine and olanzapine) on several metabolic features. These include overweight/obesity, dyslipidemia, development of new-onset type 2 diabetes, worsening of pre-existing diabetes and diabeti...

ea0032p1027 | Thyroid (non-cancer) | ECE2013

Thyroid diffuse lipomatosis: a rare and benign disease

Lau Eva , Freitas Paula , Goncalves Frederica , Pardal Joana , Eloy Catarina , Matos-Lima Luis , Carvalho Davide

Introduction: Diffuse lipomatosis of the thyroid is a very rare disease, characterized by extensive infiltration of thyroid parenchyma by mature adipose tissue. It is not accompanied by accumulation of amyloid fibrils.Clinical report: Male, 47 years old, followed in Endocrinology by hypothyroidism, since 13 years old, medicated with levothyroxine, with unremarkable growth and pshicomotor development. In 2002, thyroid echography showed a solid and heterog...

ea0029p41 | Adrenal cortex | ICEECE2012

Cancer induces adrenal and pituitary alterations during the development of cachexia-anorexia syndrome

Mazzuco T. , Crespigio J. , Fonseca E. , Macioszek M. , Lazari-Berbel L. , de Freitas R. , Souza H.

Introduction: Tumour cachexia-anorexia syndrome (CAS) is a complex disorder characterized by progressive nutritional and metabolic alterations that lead to loss of muscle and adipose tissue observed in advanced-stage cancer. CAS indicates unfavourable prognosis, regardless of cancer type. Under the influence of permanent aggression, we have evaluated the effects of the cancer cachexia development on the hypothalamic-pituitary-adrenal (HPA) axis.Methods: ...

ea0029p100 | Adrenal cortex | ICEECE2012

Exogenous corticosteroids: guilty or innocent?

Matos M. , Freitas P. , Belo S. , Frazao J. , Pimenta T. , Guimaraes S. , Carvalho D.

Introduction: The association between autoimmune diseases, including systemic lupus erythematosus (SLE), and endogenous hypercortisolism is rare. The latter is usually misinterpreted as iatrogenic in the case of patients taking exogenous systemic corticosteroid therapy. The excess endogenous glucocorticoids may play an important role in suppressing autoimmune activity. Similarly, the abrupt resolution of endogenous hypercortisolism may lead to a rebound worsening of autoimmuni...

ea0029p246 | Calcium & Vitamin D metabolism | ICEECE2012

High levels of parathormone after parathyroidectomy in primary hyperparathyroidism patients does not always mean disease recurrence…

Ferreira M. , Silva A. , Caldas A. , Dores J. , Freitas C. , Costa M. , Canha A. , Polonia J. , Vilaverde J.

Introduction: Primary hyperparathyroidism (PHPT) patients who undergo parathyroidectomy can develop isolated intact parathormone (iPTH) elevation with normal calcemia. Common causes are: renal insufficiency (RI), vitamin D deficit and hypomagnesemia.Aim: To identify clinical factors associated with iPTH elevation in patients submitted to surgery treatment.Methods: The medical records of patients admitted into Santo António&#14...

ea0026p346 | Obesity | ECE2011

AM251, a CB1 receptor antagonist, increases GLUT4 expression in adipocytes

Furuya D T , Poletto A C , Freitas H S , Machado U F

Evidences have suggested that the endocannabinoid system is overactive in obesity, resulting in enhanced endocannabinoid levels in both circulation and visceral adipose tissue. The cannabinoid CB1 receptor is expressed in the adipose tissue besides the brain. Few studies in vitro suggest that CB1 activation increases glucose uptake in adipocytes. The objective of the present study was to investigate the CB1 receptor modulation on glucose transporter GLUT4 expression, which is ...